Molecular genetics and lymphoproliferative disorders

Area of Science:

• Hematology
• Molecular Biology
• Oncology

Background:

• Morphology and surface immunostaining can be insufficient for diagnosing T- and B-cell lymphoproliferative disorders.
• Gene rearrangement studies provide critical clonality assessment when traditional methods are nondiagnostic.

Purpose of the Study:

• To highlight the utility of gene rearrangement studies in diagnosing hematologic malignancies.
• To compare traditional Southern analysis with newer Polymerase Chain Reaction (PCR) methods for gene rearrangement detection.
• To emphasize the role of clonal markers in classifying lymphomas.

Main Methods:

• Southern blot analysis for detecting T-cell receptor (TcR) and immunoglobulin (Ig) gene rearrangements.
• Polymerase Chain Reaction (PCR) for gene rearrangement analysis, offering improved turnaround time and use of paraffin-embedded material.
• Analysis of gene alterations in bcl-1, bcl-2, bcl-6, and c-myc as additional clonal markers.

Main Results:

• TcR and Ig gene rearrangements are valuable in diagnosing various hematologic disorders, including CD8 large granular lymphocyte leukemias.
• TcR gene rearrangement aids in differentiating Hodgkin's disease from T-cell non-Hodgkin's lymphoma.
• PCR demonstrates advantages over Southern analysis, including faster results and suitability for archival samples.

Conclusions:

• Gene rearrangement studies are indispensable for determining clonality in lymphoproliferative disorders.
• PCR represents an advancement in gene rearrangement analysis for clinical diagnostics.
• Analysis of multiple gene alterations, including TcR, Ig, bcl-1, bcl-2, bcl-6, and c-myc, enhances lymphoma classification.